Sanofi (SNY) Short term Debt (2009 - 2026)
Sanofi (SNY) posted Short term Debt of $8.2 billion for Q2 2026, up 61.58% sequentially from $5.1 billion in Q4 2025, and down 1.29% YoY from $8.3 billion in Q2 2025.
Sanofi (SNY) Short term Debt (2009 - 2026) Analysis & Trends
Sanofi has reported Short term Debt for 18 years, with the latest figure at $8.2 billion in Q2 2026.
- Quarterly Short term Debt fell 1.29% year-over-year to $8.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.2 billion (down 1.29% YoY) and the FY2025 annual result came in at $5.1 billion, up 12.37% from the prior year.
- Short term Debt climbed to $8.2 billion in Q2 2026 per SNY's latest filing, from $5.1 billion in the prior quarter.
- Over five years, Short term Debt peaked at $9.9 billion in Q2 2024 and troughed at $2.2 billion in Q4 2023.
- A 5-year average of $5.6 billion and a median of $5.1 billion in 2025 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2023 and 2024: Short term Debt tumbled 48.33% in 2023, then surged 104.41% in 2024.
- Over 5 years, Short term Debt stood at $4.3 billion in 2022, then slumped by 48.33% to $2.2 billion in 2023, then surged by 104.41% to $4.5 billion in 2024, then climbed by 12.37% to $5.1 billion in 2025, then surged by 61.58% to $8.2 billion in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $8.2 billion, $5.1 billion, and $8.3 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.17 Bn |
| Dec 31, 2025 | 5.05 Bn |
| Jun 30, 2025 | 8.27 Bn |
| Dec 31, 2024 | 4.50 Bn |
| Jun 30, 2024 | 9.95 Bn |
| Dec 31, 2023 | 2.20 Bn |
| Jun 30, 2023 | 5.11 Bn |
| Dec 31, 2022 | 4.26 Bn |
| Jun 30, 2022 | 3.27 Bn |
| Dec 31, 2021 | 3.64 Bn |
| Jun 30, 2021 | 2.68 Bn |
| Dec 31, 2020 | 3.30 Bn |
| Jun 30, 2020 | 3.67 Bn |
| Dec 31, 2019 | 5.04 Bn |
| Jun 30, 2019 | 4.96 Bn |
| Dec 31, 2018 | 3.01 Bn |
| Sep 30, 2018 | 53.50 Mn |
| Mar 31, 2018 | 6.81 Bn |
| Dec 31, 2017 | 1.50 Bn |
| Jun 30, 2017 | 3.56 Bn |